CVRx, Inc.
CVRx, Inc. (CVRX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CVRX · as of Jun 8, 2026
Activity summary
Buy transactions
9
P-Purchase only
Sell transactions
12
12 Months
Buy/Sell ratio
0.75
Buy/Sell (by trades)
Overall sentiment
CVRx, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CVRX insider buying and selling by quarter
CVRX insider selling · CVRX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CVRX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CVRX executive sell shares · CVRX board member insider trading · CVRX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | Nielsen Kirk G. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Jain Mudit K. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | SLATTERY JOSEPH P Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Hill, Mitch C. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Ballinger Kevin J. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | SHADAN MARTHA Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | DALE MICHAEL D Director | Award | 29,005 | — | Form 4 |
| Feb 27, 2026 | Adamson Philip B. Chief Medical Officer | Award | 41,000 | — | Form 4 |
| Mar 2, 2026 | Adamson Philip B. Chief Medical Officer | Sale | 1,262 | $10K | Form 4 |
| Mar 2, 2026 | Morrison Gregory CHIEF HUMAN RESOURCES OFFICER | Award | 34,000 | — | Form 4 |
| Feb 27, 2026 | Hykes Kevin PRES & CEO · Director | Award | 159,000 | — | Form 4 |
| Mar 2, 2026 | Hykes Kevin PRES & CEO · Director | Sale | 7,763 | $61K | Form 4 |
| Feb 27, 2026 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Award | 45,000 | — | Form 4 |
| Mar 2, 2026 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Sale | 1,284 | $10K | Form 4 |
| Feb 27, 2026 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Award | 61,000 | — | Form 4 |
| Mar 2, 2026 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Sale | 1,744 | $14K | Form 4 |
| Feb 27, 2026 | John Robert Allen Chief Revenue Officer | Award | 35,000 | — | Form 4 |
| Mar 2, 2026 | John Robert Allen Chief Revenue Officer | Sale | 3,964 | $31K | Form 4 |
| Feb 27, 2026 | Binkowski Brent CHIEF OPERATING OFFICER | Award | 15,000 | — | Form 4 |
| Feb 20, 2026 | Jain Mudit K. Director | Purchase | 46,800 | $298K | Form 4 |
| Feb 18, 2026 | Jain Mudit K. Director | Purchase | 600 | $3K | Form 4 |
| Nov 26, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 6,337 | $64K | Form 4 |
| Nov 21, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 500 | $5K | Form 4 |
| Nov 24, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 2,200 | $22K | Form 4 |
| Nov 12, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 1,000 | $10K | Form 4 |
Adamson Philip B.
Chief Medical Officer
Date
Mar 2
Shares
1,262
Price
$7.90
Value
$10K
Morrison Gregory
CHIEF HUMAN RESOURCES OFFICER
Date
Mar 2
Shares
34,000
Price
—
Value
—
VERRASTRO PAUL
CHIEF MKTG & STRAT OFFICER
Date
Feb 27
Shares
45,000
Price
—
Value
—
VERRASTRO PAUL
CHIEF MKTG & STRAT OFFICER
Date
Mar 2
Shares
1,284
Price
$7.90
Value
$10K
OASHEIM JARED
CHIEF FINANCIAL OFFICER
Date
Mar 2
Shares
1,744
Price
$7.90
Value
$14K
John Robert Allen
Chief Revenue Officer
Date
Mar 2
Shares
3,964
Price
$7.90
Value
$31K
JOHNSON & JOHNSON
10 percent owner
Date
Nov 26
Shares
6,337
Price
$10.03
Value
$64K
JOHNSON & JOHNSON
10 percent owner
Date
Nov 24
Shares
2,200
Price
$10.06
Value
$22K
JOHNSON & JOHNSON
10 percent owner
Date
Nov 12
Shares
1,000
Price
$10.00
Value
$10K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CVRX insider trading
CVRX insider trades
CVRx, Inc. (CVRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including JOHNSON & JOHNSON (10 percent owner), Jain Mudit K. (Director), Adamson Philip B. (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CVRX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For CVRx, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CVRX insider trading · 5 questionsThe insiders of CVRx, Inc. (CVRX) include executives and directors such as JOHNSON & JOHNSON (10 percent owner), Jain Mudit K. (Director), Adamson Philip B. (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026